Krónikus obstruktív tüdőbetegség (COPD): vizsgálatok itt: Dánia
36 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 10.. Ask the study team whether a trial fits you.
- No phaseTaking peopleTHERMotherapy Against Persistent Bacterial LUNG Infections
- Where
- Hellerup
- Életkor
- 18 év and over
- People
- 150
- Run by
- Chronic Obstructive Pulmonary Disease Trial Network, Denmark
See details and how to joinNCT05351242 - 2. fázisTaking peopleA Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Where
- Aalborg, Arhus, Copenhagen, Esbjerg, Hvidovre, Roskilde, Vejle
- Életkor
- 40 év to 75 év
- People
- 606 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07759245 · EU 2026-525480-41-00 - 2. fázisNot yet taking people in DániaThe MAB Trial: A Study of Tozorakimab to Reduce Lung Inflammation and Promote Lung Healing in People with COPD.
- Where
- Copenhagen
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- University Of Leicester
See details and how to join2025-522359-24-00 · EU 2025-522359-24-00 - 3. fázisTaking peopleA Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- Where
- Vejle
- Életkor
- 18 év to 80 év
- People
- 40 worldwide
- Run by
- Grifols Therapeutics LLC
See details and how to joinNCT07555483 · EU 2025-522792-29-00 - 2. fázisTaking peopleA Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Where
- Aalborg, Aarhus, Esbjerg, Hvidovre, Odense C, Roskilde
- Életkor
- 40 év and over
- People
- 987 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07082738 - 4. fázisTaking peopleA Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- Where
- Aalborg, Vejle
- Életkor
- 40 év to 85 év
- People
- 218 worldwide
- Run by
- Sanofi
See details and how to joinNCT07053423 - 3. fázisTaking peopleEfficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Where
- Aalborg, Hvidovre, Næstved, Odense, Vejle
- Életkor
- 40 év to 80 év
- People
- 942 worldwide
- Run by
- Sanofi
See details and how to joinNCT07190209 · EU 2024-518016-39-00 - No phaseCsak meghívásosLong-term Effects and Maintenance of Exercise Habits in Individuals With COPD
- Where
- Copenhagen
- Életkor
- 40 év to 80 év
- People
- 66
- Run by
- Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT07870655 - 3. fázisTaking peopleA Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Where
- Aalborg, Hvidovre, Næstved, Odense C, Vejle
- Életkor
- 40 év to 80 év
- People
- 990 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06878261 · EU 2024-517457-27-00 - 2. fázisNot yet taking people in DániaA Randomized, Double-Blind, Placebo-controlled, Parallel Arm, 52-week Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of Two Doses of EXPD-101 in Participants with COPD
- Where
- Esbjerg, Odense C, Roskilde, Vejle
- Életkor
- 18 év and over
- People
- 183 worldwide
- Run by
- Expedition Therapeutics Inc.
See details and how to join2026-525216-34-00 · EU 2026-525216-34-00 - 3. fázisTaking peopleDepemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
- Where
- Aalborg, Hvidovre, Roskilde, Vejle
- Életkor
- 40 év to 80 év
- People
- 981 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06959095 · EU 2024-520418-22-00 - 4. fázisTaking peopleStandard vs Targeted Oxygen Therapy Prehospital for Chronic Obstructive Pulmonary Disease
- Where
- Aarhus N
- Életkor
- 40 év and over
- People
- 1888
- Run by
- Central Denmark Region
See details and how to joinNCT05703919 · EU 2022-502003-30-00 - 3. fázisTaking peopleA Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Where
- Aalborg, Copenhagen Nv, Esbjerg, Hvidovre, Næstved, Vejle
- Életkor
- 40 év to 80 év
- People
- 5250 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06283966 · EU 2023-507407-59-00 - No phaseTaking peoplePulmonary and Total Blood Volume in COPD
- Where
- Copenhagen
- Életkor
- 45 év to 80 év
- People
- 32
- Run by
- Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT07428785 - No phaseTaking peopleRisk-Based Lung Cancer Detection in COPD Patients
- Where
- Vejle
- Életkor
- 50 év and over
- People
- 1000
- Run by
- Vejle Hospital
See details and how to joinNCT07848815 - No phaseTaking peopleAn Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Where
- Copenhagen
- Életkor
- 40 év to 80 év
- People
- 200 worldwide
- Run by
- Pulmonx Corporation
See details and how to joinNCT06035120 - 3. fázisTaking peopleA Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Where
- Copenhagen Nv
- Életkor
- 40 év to 80 év
- People
- 990 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06883305 · EU 2024-517458-90-00 - 2. fázisTaking peopleA study to investigate the effect of AZD6793 in participants with moderate to very severe chronic obstructive pulmonary disease
- Where
- Aalborg, Aarhus N, Esbjerg, Hvidovre, Odense C, Roskilde
- Életkor
- 18 év and over
- People
- 307 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-520473-40-00 · EU 2025-520473-40-00 - 3. fázisTaking peopleeValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- Where
- Aalborg, Hvidovre, Roskilde, Vejle
- Életkor
- 40 év to 75 év
- People
- 1196 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07177339 · EU 2025-521108-23-00 - No phaseTaking peopleUnilateral vs. Bilateral Lung Volume Reduction Surgery
- Where
- Copenhagen
- Életkor
- 18 év to 75 év
- People
- 146
- Run by
- Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT07731958 - 3. fázisCsak meghívásosLong Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency
- Where
- Arhus C, Hellerup
- Életkor
- 20 év to 72 év
- People
- 290 worldwide
- Run by
- Grifols Therapeutics LLC
See details and how to joinNCT02796937 - No phaseTaking peopleMeasurements Before and After Participation in a Health Intervention Programme in Halsnaes Municipality
- Where
- Frederiksværk
- Életkor
- 18 év and over
- People
- 194
- Run by
- Steno Diabetes Center Copenhagen
See details and how to joinNCT07641309 - 2. fázisTaking peoplePsilocybin Therapy for Psychological Distress in Palliative Patients
- Where
- Copenhagen Nv
- Életkor
- 18 év and over
- People
- 108 worldwide
- Run by
- University Medical Center Groningen
See details and how to joinNCT06782724 · EU 2023-510488-36-01 - No phaseTaking peopleEnhanced COPD Management in Suspected Lung Cancer Patients
- Where
- Vejle
- Életkor
- 18 év and over
- People
- 280
- Run by
- Ditte Krag-Hansen
See details and how to joinNCT07543601 - No phaseTaking peopleSomatic Health Screening for Adults in Outpatient Psychiatric Care in Denmark (SomaScreen)
- Where
- Copenhagen
- Életkor
- 18 év and over
- People
- 2800
- Run by
- Amager Hospital
See details and how to joinNCT07518446